- Sections
- C - Chimie; métallurgie
- C07K - Peptides
- C07K 14/635 - Hormone parathyroïdienne (parathormone); Peptides dérivés de l'hormone parathyroïdienne
Détention brevets de la classe C07K 14/635
Brevets de cette classe: 210
Historique des publications depuis 10 ans
|
15
|
18
|
7
|
23
|
20
|
17
|
21
|
7
|
10
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1170 |
29 |
| The General Hospital Corporation | 4650 |
12 |
| Board of Trustees of the University of Arkansas | 787 |
10 |
| National University Corporation Kagawa University | 213 |
8 |
| Radius Health, Inc. | 93 |
8 |
| Ochsner Clinic Foundation | 25 |
7 |
| ALZA Corporation | 143 |
4 |
| Hybio Pharmaceutical Co., Ltd. | 120 |
4 |
| Wisconsin Alumni Research Foundation | 3820 |
3 |
| Takeda Pharmaceutical Company Limited | 2943 |
3 |
| Purdue Research Foundation | 3477 |
3 |
| Asahi Kasei Pharma Corporation | 139 |
3 |
| Cadila Healthcare Limited | 323 |
3 |
| Chemical & Biopharmaceutical Laboratories of Patras S.A. | 28 |
3 |
| Eli Lilly and Company | 3720 |
3 |
| Indiana University Research and Technology Corporation | 800 |
3 |
| The Kitasato Institute | 146 |
3 |
| Amgen Inc. | 3899 |
2 |
| The Johns Hopkins University | 5533 |
2 |
| Alkem Laboratories Limited | 61 |
2 |
| Autres propriétaires | 95 |